FindTrial
Sign In

Prospective randomized controlled study for ICG combined with nano-carbon in reverse axillary lymphography for prevention of upper limb lymphedema after breast cancer surge

Prospective randomized controlled study for ICG combined with nano-carbon in reverse axillary lymphography for prevention of upper limb lymphedema after breast cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021507
Enrollment
Unknown
Registered
2019-02-24
Start date
2019-03-30
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

1:ALND+RAM
2:ALND

Sponsors

Breast and Thyroid department, the First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Aged 70 years and above; 2) Confirmed breast cancer; 3) TNM stage (0-II,IIIa); 4)Axillary lymphnode positive; 5)ASA = 3; 6)Signed CRF.

Exclusion criteria

Exclusion criteria: 1)Axillary surgery history; 2) Contraindication in operation; 3)Upper limb edema; 4)Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Upper limb edema rate;ARL positive rate;—

Secondary

MeasureTime frame
OS;RFS;—

Countries

China

Contacts

Public ContactShichao Li

Breast and Thyroid department, the First Affiliated Hospital of Army Medical University, PLA

shichaoli85@163.com+86 13452996747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026